SCHEMBL128673

SCHEMBL128673

O=C1OCOC=C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9569884 0.67
SCHEMBL9294490 0.65
SCHEMBL3744041 0.63
SCHEMBL9576805 0.61
SCHEMBL3073245 0.60
Benzene SCHEMBL7938846 0.59 NPC1 (0.33)
Potassium SCHEMBL31620483 0.58
SCHEMBL3372761 0.57 MGLL (0.37)
SCHEMBL709139 0.56
SCHEMBL6615372 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1842847-B1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO LTD (JP) 2012-03-07 EP claimed
US-7557216-B2 Process for production of 5-chloro-2,4-dihydroxypyridine TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-07 US claimed
US-20090043101-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-02-12 US claimed
EP-1842847-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 2007-10-10 EP claimed
CN-115504906-A Gelmethylpyrimidine intermediate compound 山东新时代药业有限公司 2022-12-23 CN disclosed
EP-1842847-B1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO LTD (JP) 2012-03-07 EP disclosed
EP-1842847-B1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO LTD (JP) 2012-03-07 EP disclosed
CN-101107230-B Method for producing 5-chloro-2, 4-dihydroxypyridine TAIHO PHARMACEUTICAL CO LTD 2010-05-19 CN disclosed
US-7557216-B2 Process for production of 5-chloro-2,4-dihydroxypyridine TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-07 US disclosed
US-7557216-B2 Process for production of 5-chloro-2,4-dihydroxypyridine TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-07 US disclosed
US-20090043101-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-02-12 US disclosed
US-20090043101-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO., LTD. (JP) 2009-02-12 US disclosed
CN-101107230-A Method for producing 5-chloro-2, 4-dihydroxypyridine TAIHO PHARMACEUTICAL CO LTD (JP) 2008-01-16 CN disclosed
EP-1842847-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 2007-10-10 EP disclosed
EP-1842847-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 2007-10-10 EP disclosed
WO-2006080339-A1 PROCESS FOR PRODUCTION OF 5-CHLORO-2,4-DIHYDROXYPYRIDINE TAIHO PHARMACEUTICAL CO., LTD. (JP) 2006-08-03 WO disclosed